Connecting the Dots for Pharma
Pharmaceutical Technology Europe
; 34(6):26-28, 2022.
Article
Dans Anglais
| ProQuest Central | ID: covidwho-20243766
ABSTRACT
A major driver for innovation within the bio/pharma sector has been the COVID-19 pandemic, which propelled advances such as the approval of messenger RNA (mRNA) vaccines at record-breaking speeds and led to many companies pivoting to deal with the urgent requirements for capacity and supply chain flexibility needed to overcome pandemic challenges. "Before deciding on a location, we conducted extensive market research, and it quickly became clear, just by the sheer proximity of so many biopharmaceutical companies, associations, and research centres, that the event had to be in Geneva. Organized as four half-days, they will each address a theme related to the four main areas of the supply chain present in the exhibition area pharmaceutical packaging (primary and secondary), medical devices, pharmaceutical sub-contracting, and pharmaceutical equipment. The dream scenario, the real measure of success, is when a product comes to market that happened as a result of a meeting or discussion that took place at our event.
Collection:
Bases de données des oragnisations internationales
Base de données:
ProQuest Central
Les sujets:
Vaccins
langue:
Anglais
Revue:
Pharmaceutical Technology Europe
Année:
2022
Type de document:
Article
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS